Stem Cell Therapy for Joints in Connecticut: BMAC and MFAT

Yes, in the accurate sense: it uses your own bone marrow or fat, which contain living progenitor (stem) cells along with many other healing components. It is not an FDA-approved or FDA-cleared drug product: it is a same-day procedure performed within FDA rules (see the FDA question below). Dr. Tortland describes these procedures by what they actually are: autologous, same-day, minimally manipulated cell concentrates, not a vague "stem cell" brand name.

From you, on the day of your procedure: either your bone marrow or your own fat. No embryonic, donor, amniotic, or umbilical tissue is used. Commercial "off-the-shelf" products marketed as stem cells have generally not been shown to contain living stem cells after processing, so a clinic offering one of those products is not offering the same treatment as your own cells.

Generally, yes, when it's your own tissue used the same day. There's no rejection risk, and the most common side effects are soreness at the harvest and injection sites with a temporary flare; infection and bleeding are rare. The real safety concern is products sold as "stem cells" that come from a donor: those aren't FDA-approved for orthopedic use, and the FDA has publicly warned patients about them. Dr. Tortland uses only your own tissue, processed in-office under FDA guidelines, and screens for infection or blood-thinner use before every procedure.

No, and be cautious of any provider who tells you otherwise. These cells mainly work by signaling: releasing growth factors and anti-inflammatory molecules that calm the joint and support healing, not by turning into new cartilage. The scientist who named mesenchymal stem cells now calls them "medicinal signaling cells" for exactly this reason. The realistic goal is less pain, better function, and a slower path to surgery, not cartilage regrowth.

More than PRP, because of the extra harvest time, processing, and materials involved, but there's no flat number until your evaluation. Exact pricing is quoted in writing once your target area and the volume needed are known, and nothing is charged before you have that written plan.

Most patients tolerate it well. Both harvest sites are fully numbed first, so you'll feel pressure or pulling rather than sharp pain. For BMAC, marrow is drawn from the back of the pelvis under ultrasound guidance in under 20 minutes. For MFAT, a small amount of fat is taken from the abdomen or flank using a mini-liposuction technique, in about 30 minutes, with no stitches or general anesthesia. Light sedation is available if you'd like it.

Not right away: this isn't like a cortisone shot. BMAC and MFAT work by shifting the healing environment in the joint, so meaningful change usually starts between weeks six and sixteen, and can keep improving for up to a year. More advanced joints tend to respond more slowly, and results depend on an accurate diagnosis and following through on rehab, which is why every plan starts with an ultrasound-guided evaluation.

Usually, yes, with one common exception: for arthritis, the plan often adds a PRP injection 4 to 6 weeks after the cellular treatment to build on the result. Beyond that, a second cellular treatment is only considered if the first gave partial improvement and follow-up ultrasound shows there's more to gain.

Yes, it's performed entirely within FDA rules: it just isn't "FDA-approved" in the drug-product sense, because no same-day autologous procedure like this is regulated that way. BMAC and MFAT here follow FDA 21 CFR Part 1271 and Section 361 of the Public Health Service Act: the tissue is your own, minimally manipulated with nothing added, and processed and re-implanted in one procedure. If a clinic claims outright "FDA approval" for a stem cell treatment, or uses cultured or donor-derived products, that's a red flag.